SunPower (SPWR) Tops Q3 EPS by 1c, Revenues Beat; Raises FY20 Revenue Outlook, Provides 4Q Revenue Guidance

Go back to SunPower (SPWR) Tops Q3 EPS by 1c, Revenues Beat; Raises FY20 Revenue Outlook, Provides 4Q Revenue Guidance

Pre-Open Stock Movers 10/28: (TUP) (CHY) (FSLR) Higher; (BBBY) (SIX) (SUM) Lower (more...)

October 28, 2020 9:27 AM EDT

Today's Pre-Open Stock Movers:

Tupperware Brands (NYSE: TUP) 20.3% HIGHER; reported Q3 EPS of $1.20, $0.83 better than the analyst estimate of $0.37. Revenue for the quarter came in at $477.2 million versus the consensus estimate of $362.75 million.

Community Health Systems (NYSE: CYH) 13.7% HIGHER; reported Q3 EPS of $0.18, $0.34 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.13 billion... More

After-Hours Stock Movers 10/27: (SRRK) (CYH) (FSLR) Higher; (SUM) (BGFV) (CHRW) Lower (more...)

October 27, 2020 6:02 PM EDT

Today's After-Hours Stock Movers:

Scholar Rock Holding Corporation (Nasdaq: SRRK) 23% HIGHER; announced that it intends to offer and sell in an underwritten public offering $150,000,000 of shares of its common stock. Stock extending Tuesday's 119% stock rise following positive data.

Community Health Systems (NYSE: CYH) 13.7% HIGHER; reported Q3 EPS of $0.18, $0.34 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.13 billion versus the consensus estimate of $2.9 billion.

First Solar (NASDAQ:... More

UBS Downgrades SunPower (SPWR) to Sell

October 27, 2020 4:32 AM EDT

UBS analyst Jon Windham downgraded SunPower (NASDAQ: SPWR) from Neutral to Sell with a price target of $11.00 (from $10.00).

The analyst comments "We downgrade SPWR from Neutral to Sell. We increase our PT from $10 to $11 based on 11.5x 2022E EV/EBITDA +... More

UPDATE: Credit Suisse Downgrades SunPower (SPWR) to Neutral

October 26, 2020 4:29 AM EDT

(Updated - October 26, 2020 5:11 AM EDT)

(updating comment)

Credit Suisse analyst Michael Weinstein downgraded SunPower (NASDAQ: SPWR) from Outperform to Neutral with a price target of $16.00 (from $12.00).

The analyst comments "Downgrade to Neutral (from Outperform)l, even while we increase our TP... More